코어라인소프트
Financials
Valuation Metrics
코어라인소프트's Market Cap is ₩373B. At end of 2025 it was ₩732B. Ranked #1894 of 2,405 in KR market (top 79%), #1178 of 1,627 on KOSDAQ (top 72%), #79 of 94 in Health Care Equipment & Services (top 84%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 37.33B KRW | KR#1,894/2,405 Sec#79/94 |
| Revenue | 5.19B KRW | KR#2,324/2,405 Sec#87/94 |
| Net Income | -13.89B KRW | KR—/2,405 Sec—/94 |
| Total Assets | 29.70B KRW | KR#2,328/2,405 Sec#87/94 |
| Net Assets | 12.96B KRW | KR#2,340/2,405 Sec#91/94 |
| Employees | 101 | KR#1,623/2,405 Sec#58/94 |
| Value | ||
| P/B | 2.88x | KR#2,124/2,405 Sec#76/94 |
| P/S | 7.20x | KR#2,234/2,405 Sec#79/94 |
| FCF Yield | -31.70% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | -107.16% | KR#2,336/2,405 Sec#89/94 |
| ROA | -46.76% | KR#2,343/2,405 Sec#91/94 |
| Op. Margin | -231.14% | KR#2,323/2,405 Sec#87/94 |
| Revenue Growth | 38.77% | KR#290/2,405 Sec#15/94 |
| Financial Health | ||
| Debt Ratio | 129.19% | KR#1,775/2,405 Sec#84/94 |
| Total Debt | 7.42B KRW | KR#1,704/2,405 Sec#55/94 |
| FCF | -11.83B KRW | KR#1,745/2,405 Sec#65/94 |
| Cash | 2.49B KRW | KR#2,192/2,405 Sec#90/94 |
| Current Ratio | 5.26x | KR#261/2,405 Sec#22/94 |
| Performance | ||
| 1Y Return | -48.89% | KR#1,918/2,405 Sec#68/94 |
| 1M Return | -20.91% | KR#1,922/2,405 Sec#80/94 |
| From 52W High | -55.65% | KR#1,435/2,405 Sec#53/94 |
| 1Y MDD | -53.73% | KR#1,120/2,405 Sec#42/94 |
| Trading | ||
| Volume | 29,045 shares | KR#1,294/2,405 Sec#46/94 |
| Trading Value | 60.0M KRW | KR#1,642/2,405 Sec#66/94 |
| Foreign Own. | 3.83% | KR#1,084/2,405 Sec#34/94 |
| Per Share | ||
| EPS | -774 KRW | KR—/2,405 Sec—/94 |
| BPS | 722 KRW | KR#2,346/2,405 Sec#90/94 |
Company Info
Established in 2012, Coreline Soft is an AI-based 3D medical image analysis solution company that has entered global markets through European and US subsidiaries. Under its AVIEW brand, the company provides diagnostic assistance services including chest and head and neck CT image analysis, lung cancer screening, chronic obstructive pulmonary disease, and coronary artery calcification. By securing projects with institutions like the National Cancer Center, it leads the global lung cancer screening market and generates customer loyalty through optimized AI technology and user experience. Coreline Soft is headquartered in Mapo-gu, Seoul.